Business · 27/04/2016

FDA Announces Public Meeting on Patient-Focused Drug Development for Organ Transplant Patients

The FDA is hosting a public meeting to gather patient perspectives on the impact of organ transplantation on daily life and to discuss scientific challenges in developing drugs to manage organ transplantation, as part of its performance commitments under the Prescription Drug User Fee Act (PDUFA V).